The oldest old and the 90+ Study

Alzheimer's and Dementia

Volumn 4, Issue 1 SUPPL. 1, 2008, Pages

  Kawas, Claudia H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Dementia; Oldest old

Indexed keywords

AMYLOID; APOLIPOPROTEIN E2; DNA; ESTROGEN;

AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; ESTROGEN THERAPY; HUMAN; INCIDENCE; LIFESTYLE; LONGEVITY; MOTOR PERFORMANCE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR;

AGED, 80 AND OVER; BRAIN; DEMENTIA; HUMANS;

EID: 38049003015     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.11.007     Document Type: Article

References (27)

1. US Census Bureau. Population projections (middle series). United States (2002). http://www.census.gov Available at: www.census.gov.
2. Evans D.A., Funkenstein H.H., Albert M.S., Sher P.A., Cook N.R., Chown M.J., et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 262 (1989) 2551-2556
3. Miech R.A., Breitner J.C.S., Zandi P.P., Khachaturian A.S., Anthony J.C., and Mayer L. Incidence of AD may decline in the early 90's for men, later for women. The Cache County Study. Neurology 58 (2002) 209-218
4. Ruitenberg A., Ott A., van Swieten J.C., Hofman A., and Breteler M.M. Incidence of dementia: does gender make a difference?. Neurobiol Aging 22 (2001) 575-580
5. Edland S.D., Rocca W.A., Petersen R.C., Cha R.H., and Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol 59 (2002) 1589-1593
6. Hall C.B., Verghese J., Sliwinski M., Chen Z., Katz M., Derby C., et al. Dementia incidence may increase more slowly after age 90: results from the Bronx Aging Study. Neurology 65 (2005) 882-886
7. Berlau D., Corrada M., Paganini-Hill A., Brookmeyer R., and Kawas C. Incidence of dementia continues to increase after age 90: results from the 90+ Study. Neurology 68 Suppl 1 (2007) S01.003
8. Yaffe K., Sawaya G., Lieberburg I., and Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279 (1998) 688-695
9. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288 (2002) 2123-2129
10. Laurin D., Verreault R., Lindsay J., MacPherson K., and Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 58 (2001) 498-504
11. Lytle M.E., Vander Bilt J., Pandav R.S., Dodge H.H., and Ganguli M. Exercise level and cognitive decline: the MoVIES Project. Alzheimer Dis Assoc Disord 18 (2004) 57-64
12. Paganini-Hill A., Corrada M.M., and Kawas C.H. Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study. Menopause 13 (2006) 12-18
13. Kawas C., Corrada M., and Paganini-Hill A. Low weight in early adulthood and later life exercise increase chances of surviving to age 90. Neurology 60 Suppl 2 (2003) S58.002
14. Wilson R.S., Bienias J.L., Evans D.A., and Bennett D.A. The Religious Orders Study: overview and relation between change in cognitive and motor speed. Aging Neuropsychol Cogn 11 (2004) 280-303
15. Wang L., Larson E.B., Bowen J.D., and van Belle G. Performance-based physical function and future dementia in older people. Arch Intern Med 166 (2006) 1115-1120
16. Corrada M., Head E., Kim R., and Kawas C. Braak and Braak staging and dementia in the oldest-old: Preliminary results from the 90+ Study. Neurology 64 Suppl 1 (2005) A276
17. Polvikoski T., Sulkava R., Myllykangas L., Notkola I., Niinistro L., Verkkoniemi A., et al. Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology 56 (2001) 1690-1696
18. Crystal H.A., Dickson D., Davies P., Masur D., Grober E., and Lipton R.B. The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol 57 (2000) 713-719
19. Katzman R., Terry R.D., DeTeresa R., Brown T., Davies P., Fuld P., et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23 (1988) 138-144
20. Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38 (1988) 1682-1687
21. Silver M.H., Newell K., Brady C., Hedley-White E.T., and Perls T.T. Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosom Med 64 (2002) 493-501
22. Berlau D.J., Kahle-Wrobleski K., Head E., Goodus M., Kim R., and Kawas C. Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon 2/epsilon 2 genotype. Arch Neurol 64 (2007) 1193-1196
23. Head E., Corrada M., Nistor M., and Kawas C. Higher levels of synaptophysin, but not GAP-43 protein are associated with intact cognitive function in the oldest-old: the 90+ Study. Neurology 66 Suppl 2 (2006) P05.974, A279
24. Corrada M.M., Kawas C.H., Mozaffar F., and Paganini-Hill A. Association of body mass index and weight change with all-cause mortality in the elderly. Am J Epidemiol 163 (2006) 938-949
25. Paganini-Hill A., Kawas C., and Corrada M. Type of alcohol consumed, changes in intake over time and mortality: the Leisure World Cohort Study. Age Ageing 36 (2007) 203-209
26. Paganini-Hill A., Kawas C., and Corrada M. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med 44 (2007) 305-310
27. Corrada M., Paganini-Hill A., and Kawas C. Intake of antioxidant vitamins, calcium, beverages and mortality: the 90+ Study. Neurology 62 Suppl 5 (2004)